A little belated news.
Gilead Science (GILD), reported on April 22, that their first quarter profit rose 21 percent due mainly to increase sales of its drugs for treating AIDS.
Source:
http://finance.yahoo.com/news/Gilead-profit-rises-a-rb-14997225.html?.v=1
Today, we can also see GILD at play due to the Mexican Swine flu.
On the Ichimoku chart, it has just break out of the ‘flatten’ kumo. However, we can see that the Chikou Span is still below the kumo; a suggestion that the bulls are not fully engaged yet.
Or to be more specific, currently its bullishness is a knee jerk reaction to the Mexican flu (on top of its recent greater than expected quarter performance).
Daily Chart here:
http://stockcharts.com/h-sc/ui?s=GILD&p=D&b=5&g=0&id=p82078841433
Related posts:
